title: Dr. Mischoulon and colleagues reply.
authors.affiliation: dmischoulon@partners.org.
authors.forename: David
authors.initials: D
authors.lastname: Mischoulon
authors.forename: Lawrence H
authors.initials: LH
authors.lastname: Price
authors.forename: Linda L
authors.initials: LL
authors.lastname: Carpenter
authors.forename: Audrey R
authors.initials: AR
authors.lastname: Tyrka
authors.forename: George I
authors.initials: GI
authors.lastname: Papakostas
authors.forename: Maurizio
authors.initials: M
authors.lastname: Fava
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use*; D015283:Citalopram / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D012436:S-Adenosylmethionine / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
chemical_list: D000928:Antidepressive Agents; D015283:Citalopram; D012436:S-Adenosylmethionine; D017367:Selective Serotonin Reuptake Inhibitors